Clover Health Investments, Corp. CLOV
Institutional shares held
127 Million
2.87M
calls
2.07M
puts
Total value of holdings
$317M
$7.18M
calls
$5.16M
puts
Market Cap
$958M
383,248,000
Shares Out.
Institutional ownership
33.09%
# of Institutions
227
We take great care to ensure that the data presented and summarized in this overview for CLOVER HEALTH INVESTMENTS, CORP. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLOV
View all-
Vanguard Group Inc Valley Forge, PA24.2MShares$60.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.5MShares$26.2 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA9.84MShares$24.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA7.51MShares$18.8 Million0.0% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA4.46MShares$11.2 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC4.01MShares$10 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.89MShares$9.73 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.53MShares$8.83 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.52MShares$8.81 Million0.01% of portfolio
Latest Institutional Activity in CLOV
Top Purchases
Top Sells
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Insider Transactions at CLOV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Indirect |
26,500
+31.59%
|
$53,000
$2.6 P/Share
|
|
Aug 08
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,535
-0.81%
|
$171,070
$2.18 P/Share
|
|
Aug 08
2025
|
Vivek Garipalli Director |
BUY
Open market or private purchase
|
Direct |
31,980
+1.69%
|
$63,960
$2.17 P/Share
|
|
Aug 07
2025
|
Vivek Garipalli Director |
BUY
Open market or private purchase
|
Direct |
415,000
+18.53%
|
$830,000
$2.24 P/Share
|
|
Aug 04
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
6,823
-0.21%
|
$13,646
$2.89 P/Share
|
|
Jul 31
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
29,513
-0.89%
|
$59,026
$2.89 P/Share
|
|
Jul 31
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
27,930
-1.64%
|
$55,860
$2.89 P/Share
|
|
Jul 31
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
25,081
-1.0%
|
$50,162
$2.89 P/Share
|
|
Jul 29
2025
|
Peter J. Kuipers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217,382
-3.42%
|
$434,764
$2.89 P/Share
|
|
Jul 23
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Open market or private sale
|
Indirect |
91,197
-6.1%
|
$273,591
$3.32 P/Share
|
|
Jul 22
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Open market or private sale
|
Indirect |
118,600
-7.35%
|
$355,800
$3.29 P/Share
|
|
Jul 07
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
2,012
-0.06%
|
$4,024
$2.85 P/Share
|
|
Jul 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,706
-0.26%
|
$17,412
$2.56 P/Share
|
|
Jul 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
19,789
-0.59%
|
$39,578
$2.58 P/Share
|
|
Jul 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,950
-2.84%
|
$617,900
$2.75 P/Share
|
|
Jun 30
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
85,596
-2.51%
|
$171,192
$2.79 P/Share
|
|
Jun 30
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
217,523
+5.99%
|
-
|
|
Jun 17
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
20,450
-0.64%
|
$40,900
$2.86 P/Share
|
|
Jun 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,404
-0.51%
|
$12,808
$2.89 P/Share
|
|
Jun 15
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.27%
|
$17,382
$2.89 P/Share
|
Last 12 Months Summary
Buy / Acquisition
8.55M
Shares
From
16
Insiders
| Grant, award, or other acquisition | 6.41M shares |
|---|---|
| Exercise of conversion of derivative security | 1.67M shares |
| Open market or private purchase | 473K shares |
Sell / Disposition
6.77M
Shares
From
13
Insiders
| Payment of exercise price or tax liability | 6.06M shares |
|---|---|
| Open market or private sale | 586K shares |
| Sale (or disposition) back to the issuer | 124K shares |